Literature DB >> 680591

Clinical and pathological study of asymptomatic HBsAg carriers in Chile.

M Velasco, M González-Cerón, C de la Fuente, A Ruiz, S Donoso, R Katz.   

Abstract

A clinical, biochemical, and pathological study was performed in 38 chronic HBsAg carriers. The study group is a part of 393 carriers found among 117 705 voluntary blood donors at the National Blood Bank, Hospital del Salvador, Santiago, Chile. None of the 38 carriers had a past history of illicit drug abuse, hepatitis, or work involving a high risk of hepatitis B virus infection. Ten individuals had a normal liver biopsy, 17 reactive non-specific hepatitis, one fatty changes, four chr onic persistent hepatitis, one aggressive hepatitis, two post-necrotic cirrhosis, and three alcoholic cirrhosis. There was not a close correlation between liver function test and liver histology. The most significant laboratory finding was the postivity of alpha fetoprotein in two cases. During the follow-up the two alpha fetoprotein patients presented a hepatocarcinoma 12 and 14 months after admission to the study.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 680591      PMCID: PMC1412024          DOI: 10.1136/gut.19.6.569

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  A "NEW" ANTIGEN IN LEUKEMIA SERA.

Authors:  B S BLUMBERG; H J ALTER; S VISNICH
Journal:  JAMA       Date:  1965-02-15       Impact factor: 56.272

2.  Primary carcinoma of the liver associated with Australia antigen.

Authors:  M Velasco; R Sorensen; A Daiber; A Carmona; R Katz
Journal:  Lancet       Date:  1971-06-05       Impact factor: 79.321

Review 3.  Australia antigen as a hepatitis virus. Variation in host response.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Am J Med       Date:  1970-01       Impact factor: 4.965

4.  Liver diseases in asymptomatic carriers of hepatitis B antigen.

Authors:  J B Simon; S K Patel
Journal:  Gastroenterology       Date:  1974-05       Impact factor: 22.682

5.  Correlation of Australia antigen with posttransfusion hepatitis.

Authors:  D J Gocke; H B Greenberg; N B Kavey
Journal:  JAMA       Date:  1970-05-04       Impact factor: 56.272

6.  Hepatic pathologic condition in asymptomatic Australia antigen carriers. A light microscopical study of 26 cases and a review of the literature.

Authors:  S S Shrago; M O Auslander; G L Gitnick
Journal:  Arch Pathol Lab Med       Date:  1977-12       Impact factor: 5.534

7.  The serum hepatitis related antigen (SH) in illicit drug users.

Authors:  C E Cherubin; R L Hargrove; A M Prince
Journal:  Am J Epidemiol       Date:  1970-05       Impact factor: 4.897

8.  Intrafamilial spread of asymptomatic hepatitis B.

Authors:  W Szmuness; E J Harley; A M Prince
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

9.  The emerging pattern of post-transfusion hepatitis.

Authors:  H J Alter; P V Holland; R H Purcell
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

10.  Limited family clustering of hepatitis B surface antigen in a Melanesian population.

Authors:  S Mazzur; N Jones
Journal:  Am J Epidemiol       Date:  1977-02       Impact factor: 4.897

View more
  4 in total

1.  Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state".

Authors:  Stephanos J Hadziyannis
Journal:  Hepatol Int       Date:  2007-06       Impact factor: 6.047

Review 2.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

Review 3.  Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.

Authors:  C J Oon; M A Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Needle biopsy of the liver: a review.

Authors:  M S Losowsky
Journal:  J R Soc Med       Date:  1982-09       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.